אינטגרילין 2 מגמל

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

EPTIFIBATIDE

Saatavilla:

MERCK SHARP & DOHME (ISRAEL - 1996) COMPANY LTD, ISRAEL

ATC-koodi:

B01AC16

Lääkemuoto:

תמיסה להזרקה

Koostumus:

EPTIFIBATIDE 2 MG/ML

Antoreitti:

תוך-ורידי

Prescription tyyppi:

מרשם נדרש

Valmistaja:

SCHERING-PLOUGH LABO. N.V , BELGIUM

Terapeuttinen ryhmä:

EPTIFIBATIDE

Terapeuttinen alue:

EPTIFIBATIDE

Käyttöaiheet:

Integrilin is indicated for the prevention of death and myocardial infarction in patients presenting with high risk unstable angina or non-Q-wave myocardial infarction. Integrilin is indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. Integrilin is also indicated as an adjunct to percutaneous transluminal coronary angioplasty (PTCA) balloon angioplasty, directional atheretomy, transluminal extraction catheter atherectomy, rotational ablation angioplasty, or excimer laser angioplasty for the prevention of abrupt closure of the treated coronary vessel and related acute ischemic cardiac complications (death, myorardial infarction, need for urgent intervention). Integrilin is intended for use with aspirin and heparin.

Valtuutus päivämäärä:

2013-10-31